Genetic Engineering & Biotechnology News

OCT15 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/883455

Contents of this Issue

Navigation

Page 34 of 37

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products Genetic Engineering & Biotechnology News | GENengnews.com | OCTOBER 15, 2017 | 33 People Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S ePUB Molecular Diagnostics in Personalized Medicine Advanced Analytical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Advanced Cell Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Beckman Coulter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 BioSpec . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Bio-Techne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Carterra . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Clinical OMICs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 GEN/Bio-Techne webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 GEN/Lonza webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Infors HT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Integra Biosciences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 MaxCyte . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,19 MilliporeSigma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,19 NanoTemper Technologies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 PerkinElmer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Promega . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Roche Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cover Tip SLAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Sonntek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Taconic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Thermo Fisher Scientific . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Trianni . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Wacker Chemie . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Advertiser Index Reprints Karen Ballen 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in print- ed or electronic form — to increase awareness of your product or company. Order today! Lysogene established a clinical advisory board, consisting of: Anupam Chakrapani, M.D.; Ronald G. Crystal, M.D.; Roberto Giugliani, M.D., Ph.D.; Bénédicte Héron, M.D.; Nicole M. Muschol, M.D.; Raymond Y. Wang, M.D.; Chester B. Whitley, M.D., Ph.D.; and Michel Zerah, M.D. Bioasis Technologies con- vened a scientific advisory board, consisting of: John H. Krystal, M.D., Jeffrey L. Cummings, M.D., and John P. Wikswo Jr., Ph.D. Andrew Norden, M.D., joined Cota as CMO. Eyevensys hired Ronald R. Buggage, M.D., as CMO., and Thierry Bordet, Ph.D., as preclinical director. Christian Fischer, Ph.D., is the new CEO of Gerrescheimer. Howard L. Kaufman, M.D., is the new CMO at Replimune. Hoth Therapeutics elected Andrew Herr, Ph.D., to its technology advisory board. Revance appointed Mark Foley to its board of directors. Michael Wyand, Ph.D., is the new CEO of Oxeia Biopharmaceuticals. OncoSec appointed Daniel J. O'Connor to its board of directors. Ocular Therapeutix welcomed Michael Goldstein, M.D., as CMO. Roger J. Lias, Ph.D., is the new president of Avid Bioservices. DermTech elected Gerald G. Krueger, M.D., to its scientific advisory board. Flugen appointed C. Boyd Clarke executive chairman. Univercells appointed Douglas A. Neugold as chairman of its board of directors. Palatin Technologies elected Anthony M. Manning, Ph.D., to its board of directors. Eppendorf welcomed Eva van Pelt to its management board. Uday Baldota joined Taro Pharmaceuticals as CEO. Classified SONNTEK,INC. -- Mini Bead Beater 24 800.617.3363 HOMOGENIZER Tissue Tearor Send your People Announcements to people@GENengnews.com Andrew Witty joined the Synthego advisory board. Witty is the former CEO of GlaxoSmithKline and director of United Health Group. He is currently chancellor of the University of Nottingham, England. Profile Teva Pharmaceuticals hired Kåre Schultz as its new president and CEO. Schultz most recently served as president and CEO of Lundbeck. Prior to that, he was COO of Novo Nordisk. Profile Bristol-Myers Squibb elected Karen Vousden, Ph.D., to its board of directors. Dr. Vous- den will serve as a member of the science and technology committee. She is currently a group leader at the Francis Crick Institute and chief scien- tist at Cancer Research UK. Profile Subscribe

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - OCT15 2017